Type 1 and type 2 diabetes, insulin resistance, glucose metabolism, and metabolic health
294 articles
New research reveals how obesity triggers chronic inflammation and how GLP-1 medications provide anti-inflammatory benefits independent of weight loss.
New research explores how GLP-1-based drugs like Ozempic and Wegovy work to treat obesity beyond simple appetite suppression.
Researchers discover how disrupted circadian rhythms in fat cells impair mitochondrial function, leading to metabolic syndrome.
Machine learning analyzes glucose patterns to identify distinct metabolic subphenotypes in type 2 diabetes patients.
New study shows DunedinPACE aging biomarker can predict who will develop metabolic syndrome years in advance, outperforming other epigenetic clocks.
Expert consensus provides updated recommendations for managing popular weight-loss medications before and after surgery.
New review explains the dual mechanisms behind GLP-1 receptor agonists' dramatic weight loss effects in both central and peripheral systems.
New research reveals how maltol, a widely used food flavoring, may weaken bones in diabetic patients by disrupting bone remodeling.
New research shows combining weight-loss medications with hormone therapy could transform health outcomes for obese men with low testosterone.
New research reveals how metabolic syndrome dramatically increases disease risk, but lifestyle interventions can halt and reverse progression.
Restoring mitochondrial complex I function in fat cells prevents obesity-related metabolic dysfunction, even without weight loss.
New research reveals cardiometabolic improvements from weight loss occur independently of where you lose fat on your body.
